PT-141 dosage subcutaneous is typically 1.75 mg for the FDA-approved form. Learn timing, frequency, men's off-label use, nasal spray differences, and safety.
For the FDA-approved form of PT-141 (bremelanotide), the standard subcutaneous dosage is 1.75 mg injected into the abdomen or thigh at least 45 minutes before anticipated sexual activity. You should not take another dose within 24 hours, and the label limits use to no more than 8 doses per month. Off-label and compounded versions - especially for men - often use different amounts, so a healthcare professional should guide any use.
What Is PT-141 and How Is It Given Subcutaneously?
PT-141 is the research name for bremelanotide, a melanocortin receptor agonist that acts on pathways in the brain rather than directly on blood vessels or hormones. The FDA approved it as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).
Subcutaneous injection is the only FDA-approved route. The medication comes in a single-use autoinjector pen that delivers the dose under the skin of the abdomen or thigh. PT-141 is not approved for men, and it is not a treatment for erectile dysfunction.
The Approved Subcutaneous Dose
The approved dose is 1.75 mg. That amount is fixed in the autoinjector; there is no need to calculate milligrams based on body weight. The label instructs users to inject at least 45 minutes before sexual activity.
If the first dose does not produce the desired effect, do not take a second dose that day. Wait at least 24 hours before considering another injection. The monthly cap is 8 doses, which means the maximum frequency is roughly twice per week.
PT-141 Dosage Subcutaneous for Men vs Women
Men often search for pt 141 dosage for men, but the FDA has not approved bremelanotide for male use. Some small studies and off-label reports have used doses ranging from 1.75 mg to 2 mg or more, yet there is no standard male dose.
Women using the approved product follow the 1.75 mg label. Compounded products may be sold in different concentrations, which can make dosing inconsistent. The table below summarizes the key differences.
| Group | Typical subcutaneous dose | FDA status |
|---|---|---|
| Premenopausal women with HSDD | 1.75 mg | Approved (Vyleesi) |
| Men (off-label) | 1.75-2 mg, varies | Not approved |
| Compounded products | Varies by pharmacy | Not FDA-approved |
Anyone considering peptide pt 141 dosage should confirm the concentration and source with a licensed clinician. Potency and purity are not guaranteed with compounded or gray-market peptides.
Some fitness forums discuss pt 141 dosage bodybuilding, but there is no evidence that bremelanotide builds muscle, burns fat, or improves athletic performance. Using PT-141 for bodybuilding is off-label and unproven, and it can cause severe nausea, blood pressure changes, and skin darkening.
PT-141 Injection Dosage: Timing and Frequency
The pt-141 injection dosage is timed around sexual activity, not taken on a daily schedule. The FDA label says to inject at least 45 minutes before. Some users report effects within 30 to 60 minutes, but individual response varies.
Do not exceed one dose in 24 hours. Do not exceed 8 doses in 30 days. Taking more does not improve results and may increase side effects such as nausea, flushing, and headache.
If you miss a planned dose, skip it. Do not double up. Keep a log of injection sites and times to avoid accidental overuse.
How Subcutaneous PT-141 Compares to Nasal Spray
Compounded nasal sprays are sometimes marketed as an alternative. The pt 141 nasal spray dosage is not standardized, and absorption through the nose can be unpredictable. Some products claim to deliver 10 mg per spray, while others use much lower amounts.
Because nasal sprays are not FDA-approved, there is no official dosing schedule. Users often report needing higher total amounts than with injection, but this varies widely. Subcutaneous injection remains the only route with a consistent, FDA-reviewed dose.
Nasal products also carry risks of inconsistent potency and contamination. They should not be used as a substitute for medical guidance.
Safety, Side Effects, and Who Should Avoid PT-141
Common side effects of subcutaneous PT-141 include nausea, flushing, headache, and injection site reactions. Nausea is the most frequent complaint and can be severe enough to stop use.
More serious risks include increased blood pressure and focal melanosis - darkening of the skin, gums, or breasts. PT-141 is contraindicated in people with uncontrolled high blood pressure or known cardiovascular disease.
PT-141 is not approved for pregnant women or people under 18. Do not use it with other medications without checking for interactions. A healthcare professional can review your history and monitor for problems.
Practical Tips for Safe Subcutaneous Dosing
- Use only a prescription product from a licensed pharmacy.
- Inject into the abdomen or thigh, rotating sites to reduce irritation.
- Wait at least 45 minutes before sexual activity.
- Never exceed 1.75 mg per 24 hours unless a doctor specifically directs otherwise.
- Stop use and seek medical help for severe nausea, chest pain, or signs of an allergic reaction.
PT-141 is a prescription medication, not a supplement. The FDA has not approved it for men, for daily use, or for bodybuilding. Any decision to use it should follow a conversation with a qualified healthcare provider.
Frequently Asked Questions
What is the typical subcutaneous dose of PT-141?
The FDA-approved dose of PT-141 (Vyleesi) is 1.75 mg injected under the skin of the abdomen or thigh. It should be taken at least 45 minutes before anticipated sexual activity. Do not take more than one dose in 24 hours or more than 8 doses per month.
Can men use PT-141 subcutaneously?
PT-141 is not FDA-approved for men. Some off-label and compounded use exists, but there is no standard male dose. Men should consult a healthcare professional before using it.
How often can you take PT-141 subcutaneous injections?
You can take PT-141 no more than once every 24 hours. The FDA label limits use to a maximum of 8 doses in 30 days. Taking it more often increases the risk of nausea, blood pressure changes, and other side effects.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.